These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24318884)

  • 1. Design and evaluation of clinically relevant SOFA-HDV ribozymes targeting HIV RNA.
    Scarborough RJ; Lévesque MV; Perreault JP; Gatignol A
    Methods Mol Biol; 2014; 1103():31-43. PubMed ID: 24318884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.
    Lainé S; Scarborough RJ; Lévesque D; Didierlaurent L; Soye KJ; Mougel M; Perreault JP; Gatignol A
    RNA Biol; 2011; 8(2):343-53. PubMed ID: 21422817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
    Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
    AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
    Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme gene therapy for hepatitis C virus infection.
    Welch PJ; Yei S; Barber JR
    Clin Diagn Virol; 1998 Jul; 10(2-3):163-71. PubMed ID: 9741642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular application of hairpin ribozyme genes against hepatitis B virus.
    Welch PJ; Tritz R; Yei S; Barber J; Yu M
    Gene Ther; 1997 Jul; 4(7):736-43. PubMed ID: 9282175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimicry of the hepatitis delta virus replication cycle mediated by synthetic circular oligodeoxynucleotides.
    Diegelman AM; Kool ET
    Chem Biol; 1999 Aug; 6(8):569-76. PubMed ID: 10421762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating a new generation of ribozymes in order to target HCV.
    Lévesque MV; Lévesque D; Brière FP; Perreault JP
    PLoS One; 2010 Mar; 5(3):e9627. PubMed ID: 20224783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and Ribozymes.
    Scarborough RJ; Gatignol A
    Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA enzymes (ribozymes) as antiviral therapeutic agents.
    Rossi JJ; Sarver N
    Trends Biotechnol; 1990 Jul; 8(7):179-83. PubMed ID: 1366622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and function of triplex hairpin ribozymes.
    Aquino-Jarquin G; Rojas-Hernández R; Alvarez-Salas LM
    Methods Mol Biol; 2010; 629():323-38. PubMed ID: 20387159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A triplex ribozyme expression system based on a single hairpin ribozyme.
    Aquino-Jarquin G; Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
    Oligonucleotides; 2008 Sep; 18(3):213-24. PubMed ID: 18707243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV RNA dimerisation interference by antisense oligonucleotides targeted to the 5' UTR structural elements.
    Reyes-Darias JA; Sánchez-Luque FJ; Berzal-Herranz A
    Virus Res; 2012 Oct; 169(1):63-71. PubMed ID: 22820401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozymes that cleave reovirus genome segment S1 also protect cells from pathogenesis caused by reovirus infection.
    Shahi S; Shanmugasundaram GK; Banerjea AC
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4101-6. PubMed ID: 11274435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes.
    Prislei S; Buonomo SB; Michienzi A; Bozzoni I
    RNA; 1997 Jun; 3(6):677-87. PubMed ID: 9174101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.